Literature DB >> 26659415

The Electronic Medical Record's Role in Support of Smoking Cessation Activities.

Jaeyong Bae1, Eric W Ford2, Timothy R Huerta3.   

Abstract

INTRODUCTION: Electronic medical records (EMRs) have been touted as a tool for improving physicians' performance in the effort to reduce smoking harm. The purpose of this research is to assess EMR sophistication and functionality in relationship to smoking status documentation, cessation counseling, and medication use in ambulatory care settings.
METHODS: Regression analyses of the 2007-2010 National Ambulatory Medical Care Survey were conducted to measure the association between EMR sophistication and smoking status recorded, smoking cessation counseling, and medication prescribing during visits. In general, EMR sophistication is measured by the presence of interactive EMR capabilities where "advanced" systems include functionalities for clinical decision support and management of orders and tests compared to "basic" systems.
RESULTS: Physicians using advanced EMR systems were significantly more likely to record smoking status, counsel patients on smoking cessation, and document prescribing medications to support cessation efforts than doctors using less sophisticated technologies.
CONCLUSIONS: Generally, the use of more sophisticated EMRs were associated with improved smoking cessation support by physicians in the ambulatory environment. Physicians purchasing or upgrading an EMR system should include the smoking cessation support features as part of their requirements. Future stages in the federal government's EMR Meaningful Use incentives and rewards program should include explicit metrics related to smoking cessation activities. IMPLICATIONS: The findings of this article contribute to current literature on EMR and smoking cessation by providing empirical evidence that advanced EMR systems with features like clinical reminders serve to influence the structure of the clinical encounter such that clinicians are significantly more likely to document smoking, engage in counseling, and prescribe medications. Physicians purchasing or upgrading an EMR system should include the smoking cessation support features as part of their requirements. Future stages in the federal government's EMR Meaningful Use incentives and rewards program should include explicit metrics related to smoking cessation activities.
© The Author 2015. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2015        PMID: 26659415     DOI: 10.1093/ntr/ntv270

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  10 in total

Review 1.  Tobacco Use Assessment and Treatment in Cancer Patients: A Scoping Review of Oncology Care Clinician Adherence to Clinical Practice Guidelines in the U.S.

Authors:  Sarah N Price; Jamie L Studts; Heidi A Hamann
Journal:  Oncologist       Date:  2018-11-16

2.  Smoking-Cessation Assistance: Before and After Stage 1 Meaningful Use Implementation.

Authors:  Steffani R Bailey; John D Heintzman; Miguel Marino; R Lorie Jacob; Jon E Puro; Jennifer E DeVoe; Tim E Burdick; Brian L Hazlehurst; Deborah J Cohen; Stephen P Fortmann
Journal:  Am J Prev Med       Date:  2017-03-29       Impact factor: 5.043

3.  Increased Reach and Effectiveness With a Low-Burden Point-of-Care Tobacco Treatment Program in Cancer Clinics.

Authors:  Alex T Ramsey; Timothy B Baker; Faith Stoneking; Nina Smock; Jingling Chen; Giang Pham; Aimee S James; Graham A Colditz; Ramaswamy Govindan; Laura J Bierut; Li-Shiun Chen
Journal:  J Natl Compr Canc Netw       Date:  2022-05       Impact factor: 12.693

4.  Tobacco Use Prevalence and Smoking Cessation Pharmacotherapy Prescription Patterns Among Hospitalized Patients by Medical Specialty.

Authors:  A Benjamin Srivastava; Alex T Ramsey; Leslie D McIntosh; Thomas C Bailey; Sherri L Fisher; Louis Fox; Mario Castro; Yinjiao Ma; Timothy B Baker; Li-Shiun Chen; Laura J Bierut
Journal:  Nicotine Tob Res       Date:  2019-04-17       Impact factor: 4.244

5.  Validation of Veterans Affairs Electronic Medical Record Smoking Data Among Iraq- and Afghanistan-Era Veterans.

Authors:  Patrick S Calhoun; Sarah M Wilson; Jeffrey S Hertzberg; Angela C Kirby; Scott D McDonald; Paul A Dennis; Lori A Bastian; Eric A Dedert; Jean C Beckham
Journal:  J Gen Intern Med       Date:  2017-08-14       Impact factor: 6.473

6.  Utility of Using Cancer Registry Data to Identify Patients for Tobacco Treatment Trials.

Authors:  Paul Krebs; Erin Rogers; Amanda Greenspan; Keith Goldfeld; Lei Lei; Jamie S Ostroff; Bridgette E Garrett; Behnoosh Momin; S Jane Henley
Journal:  J Registry Manag       Date:  2019

7.  Mining Electronic Health Records to Promote the Reach of Digital Interventions for Cancer Prevention Through Proactive Electronic Outreach: Protocol for the Mixed Methods OptiMine Study.

Authors:  Michael S Amato; Sherine El-Toukhy; Lorien C Abroms; Henry Goodfellow; Alex T Ramsey; Tracey Brown; Helena Jopling; Zarnie Khadjesari
Journal:  JMIR Res Protoc       Date:  2020-12-31

8.  System-Level Quality Improvement Initiatives for Tobacco Use in a Safety-Net Health System During the COVID-19 Pandemic.

Authors:  Kara Chung; Henry Rafferty; Leslie W Suen; Maya Vijayaraghavan
Journal:  J Prim Care Community Health       Date:  2022 Jan-Dec

9.  An intervention based on the Electronic Medical Record to improve smoking cessation guidance in an urban tertiary care center emergency department.

Authors:  Michael P Phelan; Balaji Nithianandam; Nathan Eikoff; Daniel Good; Fredric M Hustey; Stephen Meldon
Journal:  Tob Prev Cessat       Date:  2019-05-06

10.  Perceived Value of Electronic Medical Records in Community Health Services: A National Cross-Sectional Survey of Primary Care Workers in Mainland China.

Authors:  Zining Xia; WenJuan Gao; Xuejuan Wei; Yingchun Peng; Hongjun Ran; Hao Wu; Chaojie Liu
Journal:  Int J Environ Res Public Health       Date:  2020-11-17       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.